CClinicalTrials.gg
CompletedNCT06471985CPHUpdated Apr 6, 2025

CoPainHell: The Analgesic Effect of Alcohol and Music

An interventional study of Music and pain in Acute Pain, sponsored by Eske Kvanner Aasvang. Completed at 1 site in Denmark. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-04-06.

Sponsored by Eske Kvanner Aasvang · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
45
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The study is a 2x2 randomized crossover study. Participants are randomized to listen to one of two music tracks: "Orinoco Flow" by Enya or "Raining Blood" by Slayer. Prior to the intervention, participants' breath alcohol levels are measured through a breathalyzer test. The intervention involves a cold water test, where the participant's dominant hand is submerged in water at 4-5 degrees Celsius. Participants are instructed to keep their hand in the water until the pain becomes too intense, but no longer than 5 minutes.

Two hours after the first test, the same procedure is repeated, but participants listen to the other music track than they did during the first test. Participants receive no instructions on how to behave during the 2-hour interval.

The experiment takes place during the music festival CopenHell (June 19-22, 2024), provided that there is approval from relevant authorities.

Two hours after the first test, the same procedure is repeated, but participants listen to the other music track than in the first test. Participants are given no instructions on how to behave during the 2-hour interval.

Read the detailed description

This study is a 2x2 factorial randomized cross-over study investigating the effect of alcohol and music on analgesia. Enrollment will be at the Festival Site of Copenhell, Refshalevej 185, 1432 København K, Denmark. Participants meeting inclusion criteria will be enrolled.

Following the written and oral informed consent to participate in the trial, participants will fill out a questionnaire of demographics information.

When performing the intervention, participants will initially have their blood alcohol content measured with a breath analyzer measuring Breath Alcohol Content (BrAC). After BrAC measurement, the study participants will undergo ''cold pressor test'' (CPT) pain stimulation on their dominant arm:

Prior to the CPT, the participants will be randomized to either listening to the calm and relaxing song "Orinoco Flow" by Enya or the song "Raining Blood" by Slayer, considered one of the most iconic heavy-metal music numbers, during the test.

After the pain stimulation test the participants will undergo a wash out period lasting at least 2 hours where participants enjoy the festival on their own without any instructions.

Following the wash-out period the participants will return to another BrAC measurement followed by an identical CPT. However, this time they will listen to the opposite song than before. The investigators will expect that the participants will have a different alcohol concentration in the breath (higher/lower) for the second pain test.

The investigators will include up to 45 participants.

Explanation of Cold Pressor Test:

The CPT is performed with a cold-water bath with a temperature of 4° - 5° degrees cold circulating water. The participant will be asked to submerge their dominant hand and wrist in the cold water and a timer will be started simultaneously. Participants are asked to keep the hand in the water until pain threshold and pain tolerance is reached. Participants are allowed to move the hand or keep it still as they wish, and they are informed that there will be a time cap of 5 minutes to ensure no permanent damage.

The water will be circulated with an Eheim 1046 universal pump (Eheim, Deizisau, Germany), and temperature monitored with a Testo 925 waterproof precision thermometer (Testo, Lenzkirch, Germany). The CPT setup is identical to a prior study performed by the same author.

Prior to stimulation the participants will be thoroughly informed of the procedure by an investigator using the instructions of a previous study.

02

Conditions studied

  • Acute Pain

Browse trials for

03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Participants ≥ 18 years old
  • Informed consent
  • Breath alcohol concentration ranging from 0.0 to 1.5 permille and deemed fit by the investigator at the time of giving informed consent

Exclusion criteria

Exclusion Criteria:

  • Wounds on dominant arm
  • Current illness (a flu, cold etc.)
  • Persons with diabetes because of the risk of peripheral neuropathies or other know peripheral sensibility paresthesia
  • Circulation issues (especially Raynaud's syndrome)
  • Pregnancy

Pull-out criteria

  • Breath alcohol concentration > 2.5 permille and/or deemed unfit to participate by the investigator at the second pain test
04

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
45 participants (actual)

Study arms

  • Active comparator
    Enya + Pain test

    In this arm, participants will listen to Enya in headphones while being exposed to the Cold Pressor Test.

    Combination Product: Music and pain

  • Active comparator
    Slayer + Pain test

    In this arm, participants will listen to Slayer in headphones while being exposed to the Cold Pressor Test.

    Combination Product: Music and pain

Interventions

  • Combination productMusic and pain

    In both arms of the study the participant will take the same pain test. They will either listen to Enya or slayer, depending on the arm

05

What researchers measure

Primary outcomes

  1. pain responsiveness

    Pain responsiveness will be measured on the VAS, where an investigator will ask the participants to rate their experienced pain from 1-10. The VAS will be rated at the start of CPT + 30 seconds, 60 seconds, 90, 120, 180, 240 and 300 seconds or when reaching the pain tolerance (up to 5 minutes), where the test will end whichever comes first. VAS: Visuel Analog Scale. Values 0-10, where 0 is no pain at al and 10 is the worst pain imaginable

    Time frame: 300 seconds

Secondary outcomes

  1. pain threshold and pain tolerance

    Pain threshold is measured as the number of seconds passed from the beginning of the pain stimulation till the participant says "pain", when stimulus evolves from being unpleasant to painful. Pain tolerance is measured as the number of seconds passed from the beginning of pain stimulation till the participant can't bear the pain anymore and says "pain limit".

    Time frame: five minutes

06

Study locations

1 site
  • Copenhell metal Festival
    Copenhagen, 2100, Denmark
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT06471985
Lead sponsor
Eske Kvanner Aasvang
Responsible party
Eske Kvanner Aasvang (Professor, Rigshospitalet, Denmark) — Sponsor-investigator
First posted
Jun 24, 2024
Start date
Jun 19, 2024
Primary completion
Jun 22, 2024
Completion
Dec 31, 2024
Last update
Apr 6, 2025

Study contacts

Eske K Aasvang
principal investigator · Rigshospitalet, Denmark

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion